comparemela.com

Latest Breaking News On - Travere therapeutics - Page 1 : comparemela.com

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 11, 2024 Travere Therapeutics, Inc., today announced that on June 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants to three new.

Compensation committeeTherapeutics incIncentive planNasdaq listing ruleTravere therapeutics

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Therapeutics incCompensation committeeIncentive planNasdaq listing ruleTravere therapeutics

Avidity Partners Management LP Sells 495,990 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX)

Avidity Partners Management LP cut its holdings in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 37.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 827,010 shares of the company’s stock after selling 495,990 shares during the period. Avidity Partners Management […]

Dynamic technology lab private ltdTravere therapeutics incCharles schwab investment management incCanaccord genuity groupWells fargo companyVanguard group incSchonfeld strategic advisorsJacobs levy equity management incExchange commissionAvidity partners managementTravere therapeuticsFree reportPartners managementStrategic advisorsLevy equity managementTechnology lab private ltd

Travere Therapeutics (NASDAQ:TVTX) Trading Down 6.1%

Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) traded down 6.1% during trading on Thursday . The company traded as low as $7.32 and last traded at $7.35. 219,510 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 1,230,257 shares. The stock had previously closed at […]

Canaccord genuity groupChina universal asset management coDynamic technology lab private ltdNisa investment advisorsEntrypoint capitalTravere therapeutics incWells fargo companyTravere therapeuticsGet free reportGenuity groupPoint capitalInvestment advisorsUniversal asset managementIga nephropathyTravere therapeutics daily

Travere Therapeutics, Inc. (NASDAQ:TVTX) Stake Boosted by Crestline Management LP

Crestline Management LP raised its position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 32.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,423 shares of the company’s stock after purchasing an additional 20,002 shares during the quarter. Crestline […]

United statesE fund management coMirae asset global investments coExchange commissionWells fargo companyTravere therapeutics incFund management coCanaccord genuity groupCrestline managementTravere therapeuticsFree reportRetirement systemState retirement systemAsset global investmentsFund managementGet free report

vimarsana © 2020. All Rights Reserved.